1,009
Views
11
CrossRef citations to date
0
Altmetric
Research Papers

Preclinical development of HIvax: Human survivin highly immunogenic vaccines

, , , , , , , , , , , , , , , & show all
Pages 1585-1595 | Received 14 Apr 2015, Accepted 07 May 2015, Published online: 06 Jul 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Angela Bononi, Andrea Napolitano, Harvey I Pass, Haining Yang & Michele Carbone. (2015) Latest developments in our understanding of the pathogenesis of mesothelioma and the design of targeted therapies. Expert Review of Respiratory Medicine 9:5, pages 633-654.
Read now

Articles from other publishers (10)

Yuanting Zhang, Yihan Zhou, Min Gong, Qing Zhang, Qiujie Zheng, Yuanying Shen, Wenshu Lu & Shisong Jiang. (2023) Survivin‐Based Recombinant Overlapping Peptides Induce T Lymphocyte Cytotoxicity and Prolong the Survival in In Vivo Melanoma Model. Advanced Therapeutics 6:11.
Crossref
Malin C. Erlandsson, Karin M.E. Andersson, Nina Y. Oparina, Venkataragavan Chandrasekaran, Tibor Saghy, Anastasios Damdimopoulos, Maria-Jose Garcia-Bonete, Zakaria Einbeigi, Sofia T. Silfverswärd, Marcela Pekna, Gergely Katona & Maria I. Bokarewa. (2022) Survivin promotes a glycolytic switch in CD4+ T cells by suppressing the transcription of PFKFB3 in rheumatoid arthritis. iScience 25:12, pages 105526.
Crossref
Anne S. De Groot, Leonard Moise, Frances Terry, Andres H. Gutierrez, Pooja Hindocha, Guilhem Richard, Daniel Fredric Hoft, Ted M. Ross, Amy R. Noe, Yoshimasa Takahashi, Vinayaka Kotraiah, Sarah E. Silk, Carolyn M. Nielsen, Angela M. Minassian, Rebecca Ashfield, Matt Ardito, Simon J. Draper & William D. Martin. (2020) Better Epitope Discovery, Precision Immune Engineering, and Accelerated Vaccine Design Using Immunoinformatics Tools. Frontiers in Immunology 11.
Crossref
Peter R. Hoffmann, Fukun W. Hoffmann, Thomas A. Premeaux, Tsuyoshi Fujita, Elisa Soprana, Maddalena Panigada, Glen M. Chew, Guilhem Richard, Pooja Hindocha, Mark Menor, Vedbar S. Khadka, Youping Deng, Lenny Moise, Lishomwa C. Ndhlovu, Antonio Siccardi, Andrew D. Weinberg, Anne S. De Groot & Pietro Bertino. (2019) Multi-antigen Vaccination With Simultaneous Engagement of the OX40 Receptor Delays Malignant Mesothelioma Growth and Increases Survival in Animal Models. Frontiers in Oncology 9.
Crossref
Helene Woyczesczyk & Karim Essani. 2018. Melanoma. Melanoma 515 524 .
Ulrike Sauermann, Antonia Radaelli, Nicole Stolte-Leeb, Katharina Raue, Massimiliano Bissa, Carlo Zanotto, Michael Krawczak, Matthias Tenbusch, Klaus Überla, Brandon F. Keele, Carlo De Giuli Morghen, Sieghart Sopper & Christiane Stahl-Hennig. (2017) Vector Order Determines Protection against Pathogenic Simian Immunodeficiency Virus Infection in a Triple-Component Vaccine by Balancing CD4 + and CD8 + T-Cell Responses . Journal of Virology 91:23.
Crossref
Xiaoyu Wang, Defang Zhou, Guihua Wang, Libo Huang, Qiankun Zheng, Chengui Li & Ziqiang Cheng. (2017) A novel multi-variant epitope ensemble vaccine against avian leukosis virus subgroup J. Vaccine 35:48, pages 6685-6690.
Crossref
Himani Garg, Prerna Suri, Jagdish C. Gupta, G. P. Talwar & Shweta Dubey. (2016) Survivin: a unique target for tumor therapy. Cancer Cell International 16:1.
Crossref
Qamar M. Sheikh, Derek Gatherer, Pedro A Reche & Darren R. Flower. (2016) Towards the knowledge-based design of universal influenza epitope ensemble vaccines. Bioinformatics 32:21, pages 3233-3239.
Crossref
Andrea Napolitano & Michele Carbone. (2016) Malignant Mesothelioma: Time to Translate?. Trends in Cancer 2:9, pages 467-474.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.